Verlinden Michiel, Nys Herman, Ectors Nadine, Huys Isabelle
1 Clinical Pharmacology and Pharmacotherapy , KU Leuven, Belgium .
Biopreserv Biobank. 2014 Dec;12(6):415-22. doi: 10.1089/bio.2014.0034.
The current study investigates whether access arrangements relevant for biobanking contain clear information on key access conditions. It furthermore assesses the extent to which these access conditions are harmonized across biobank initiatives.
A comparative analysis was conducted of access arrangements developed by 26 organizations, 36 biobank networks, and 20 biobanks worldwide.
The study demonstrates a lack of clear information on 21 key access conditions relevant for biobanking. Furthermore, it confirms that the harmonization across biobank initiatives is limited.
Many biobank initiatives need to be more transparent on how they apply the studied access conditions.
本研究调查与生物样本库相关的获取安排是否包含有关关键获取条件的明确信息。此外,还评估了这些获取条件在各生物样本库计划中协调一致的程度。
对全球26个组织、36个生物样本库网络和20个生物样本库制定的获取安排进行了比较分析。
研究表明,对于与生物样本库相关的21个关键获取条件,缺乏明确信息。此外,研究证实各生物样本库计划之间的协调有限。
许多生物样本库计划在如何应用所研究的获取条件方面需要更加透明。